Consistent with our results, a previous study showed that silencing SIRT1 in human prostate cancer cells decreases cell migration in vitro and metastasis in vivo in immunodeficient mice, which is significantly independent of the effects of SIRT1 on prostate cancer growth and survival mediated by inducing EMT [25]. This evidence concerns the gene SIRT1 and prostate cancer.